ALX Oncology Holdings Inc. (ALXO) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 150K | 0 | 0 | 0 | 0 | 0 | 0 | 220K | 214K | 0 | 0 | 0 |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | -150K | 0 | 0 | 0 | 0 | 0 | 0 | -220K | -214K | 0 | 0 | 0 |
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | - | - | - | 100% | 100% | - | - | - | - | 100% | - | - |
| Operating Expenses | 18.82M | 23.02M | 22.53M | 26.65M | 31.82M | 30.61M | 32.57M | 41.3M | 37.55M | 48.02M | 53.27M | 36.78M |
| OpEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 5.36M | 5.38M | 5.09M | 5.45M | 7.93M | 7.08M | 6.1M | 6.65M | 5.83M | 6.24M | 7.51M | 7.29M |
| SG&A % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Research & Development | 13.61M | 17.64M | 17.44M | 18.02M | 23.89M | 23.53M | 26.47M | 34.65M | 31.72M | 41.78M | 45.77M | 29.48M |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | -150K | 0 | 0 | 1000K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -18.97M | -23.02M | -22.53M | -26.65M | -31.82M | -30.61M | -32.57M | -41.52M | -37.76M | -48.02M | -53.27M | -36.78M |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | 40.4% | 24.8% | 30.81% | 35.83% | 15.74% | 36.25% | 38.87% | -12.91% | -17.26% | -49.05% | -45.24% | -8.84% |
| EBITDA | -18.82M | -22.87M | -22.38M | -26.46M | -31.61M | -30.4M | -32.34M | -41.3M | -37.55M | -47.82M | -53.07M | -36.57M |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA Growth % | 40.47% | 24.77% | 30.81% | 35.95% | 15.82% | 36.43% | 39.05% | -12.95% | -17.37% | -48.89% | -45.04% | -8.5% |
| D&A (Non-Cash Add-back) | 150K | 151K | 153K | 191K | 211K | 214K | 224K | 220K | 214K | 207K | 209K | 207K |
| EBIT | -18.97M | -22.46M | -21.74M | -25.54M | -30.35M | -28.74M | -30.26M | -38.97M | -35.15M | -45.06M | -50.6M | -33.79M |
| Net Interest Income | 851K | 190K | 394K | 701K | 1.08M | 1.45M | 1.86M | 2.13M | 2.19M | 2.58M | 2.29M | 2.29M |
| Interest Income | 1.18M | 573K | 802K | 1.11M | 1.48M | 1.88M | 2.3M | 2.56M | 2.62M | 3M | 2.68M | 2.67M |
| Interest Expense | 331K | 383K | 408K | 405K | 406K | 427K | 446K | 429K | 427K | 415K | 391K | 372K |
| Other Income/Expense | 1.04M | 173K | 388K | 699K | 1.07M | 1.45M | 1.86M | 2.13M | 2.18M | 2.55M | 2.29M | 2.62M |
| Pretax Income | -17.93M | -22.85M | -22.14M | -25.95M | -30.75M | -29.16M | -30.71M | -39.4M | -35.58M | -45.47M | -50.99M | -34.16M |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -17.93M | -22.85M | -22.14M | -25.95M | -30.75M | -29.16M | -30.71M | -39.4M | -35.58M | -45.47M | -50.99M | -34.16M |
| Net Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | 41.71% | 21.65% | 27.89% | 34.14% | 13.57% | 35.87% | 39.78% | -15.34% | -17.88% | -48.07% | -44.37% | -3.76% |
| Net Income (Continuing) | -17.93M | -22.85M | -22.14M | -25.95M | -30.75M | -29.16M | -30.71M | -39.4M | -35.58M | -45.47M | -50.99M | -34.16M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.33 | -0.42 | -0.41 | -0.49 | -0.58 | -0.55 | -0.58 | -0.76 | -0.71 | -0.93 | -1.24 | -0.84 |
| EPS Growth % | 43.1% | 23.64% | 29.31% | 35.53% | 18.31% | 40.86% | 53.23% | 9.52% | -1.43% | -24% | -42.53% | -6.33% |
| EPS (Basic) | -0.33 | -0.42 | -0.41 | -0.49 | -0.58 | -0.55 | -0.58 | -0.76 | -0.71 | -0.93 | -1.24 | -0.84 |
| Diluted Shares Outstanding | 54.28M | 54.28M | 53.58M | 53.45M | 53.36M | 52.8M | 52.69M | 51.83M | 50.12M | 49M | 41.15M | 40.88M |
| Basic Shares Outstanding | 54.28M | 54.28M | 53.58M | 53.45M | 53.36M | 52.8M | 52.69M | 51.83M | 50.12M | 49M | 41.15M | 40.88M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |